- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on EGFR TKIs
Total 347 results
-
Fujian Cancer HospitalNot yet recruitingNSCLC | EGFR | Third-generation TKI
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
GenoSaberSun Yat-sen University; Shanghai Chest Hospital; Shanghai Pulmonary Hospital,...UnknownNon Small Cell Lung Cancer | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Sun Yat-sen UniversityRecruitingNon-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline MutationsChina
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Centro de Tratamiento e Investigación sobre Cáncer...Not yet recruitingNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Exon 19 Deletion | EGFR G719X | EGFR Exon 21 MutationColombia
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingChemotherapy | Surgery | Non Small Cell Lung Cancer | EGFR Activating Mutation | EGFR TKI
-
China Medical University HospitalNot yet recruitingNon-small Cell Lung Cancer | EGFR Gene Mutation | EGFR-TKI Resistant Mutation
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaboratorsRecruitingLung Cancer, Non-small Cell | Circulating Tumor DNA | EGFR Gene Mutation | EGFR-TKI Resistant Mutation | Primary ResistanceChina
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
Li Zhang, MDRecruitingThe Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of PatientsChina
-
Degan LuWu Jieping Medical FoundationNot yet recruitingLung Cancer | Anlotinib | TKI Resistance | EGFR Sensitive Mutation | Pianzumab
-
Fujian Cancer HospitalUnknown
-
Shanghai Henlius BiotechNot yet recruiting
-
Fujian Cancer HospitalUnknown
-
Tianjin Medical University Second HospitalRecruiting
-
Nanfang Hospital of Southern Medical UniversityRecruitingDifferent Gene Between Different TKIs EffectionChina
-
Chinese PLA General HospitalRecruitingSolid Tumor, Adult | EGFR OverexpressionChina
-
Chinese PLA General HospitalUnknownAdvanced EGFR-positive Solid TumorsChina
-
Shanghai Henlius BiotechNot yet recruitingHLX07, nsqNSCLC, High EGFR ExpressionChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
ImmunoGen, Inc.TerminatedEGFR Positive Solid TumorsUnited States
-
Qingdao Central HospitalCompletedEGFR-TKI Resistant MutationChina
-
Changchun Intellicrown Pharmaceutical Co. LTDCovanceRecruitingAdvanced EGFR Positive Solid TumorUnited States, China
-
Bristol-Myers SquibbCompletedHER2 or EGFR Expressing Advanced Solid MalignanciesSpain, France
-
Sun Yat-sen UniversityRecruitingEGFR Tyrosine Kinase Inhibitors Plus VEGFR InhibitorsChina
-
Fudan UniversityRecruitingCarcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKIChina
-
Yuankai ShiUnknownAdvanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC PatientsKorea, Republic of, Russian Federation, Malaysia, China, Australia, Taiwan, Thailand, Indonesia, Singapore
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Chongqing University Cancer HospitalArmy Specialty Medical Center; The Second Affilicated Hospital of Chongqing...RecruitingNon-small Cell Lung Cancer | EGFR G719X | EGFR L861Q | EGFR S768IChina
-
University of Central FloridaRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | EGFR L858R | EGFR DEL19France
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Shenzhen People's HospitalUnknown
-
Nalo Therapeutics Inc.RecruitingEGFR Mutation-Related TumorsKorea, Republic of, United States, Taiwan
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Metastatic Lung Cancer | Antineoplastic Agents | Brain Metastases | Lung Neoplasm Malignant | EGFR... and other conditionsUnited States, Canada, Korea, Republic of, Japan, Taiwan
-
Incyte CorporationTerminatedAdvanced or Metastatic Solid Tumors | FGFR Mutations | FGFR TranslocationsUnited States
-
Sanoculis LtdCompletedThis Study is Obtained Under Inclusion/ Exclusion CriteriaArmenia
-
Sanoculis LtdCompletedThis Study is Conducted Under Inclusion/ Exclusion CriteriaArmenia
-
Brigham and Women's HospitalUnknownThe Focus of This Study Are New Pulse Sequences.United States
-
Fujian Cancer HospitalNot yet recruitingNon-small Cell Lung Cancer Confirmed by Histopathology or Cytology | The TNM (8th) Phase is IV | With EGFR Mutations | Meningeal Progression Occurred After Previous Platinum-containing Two-drug Chemotherapy and Third-generation EGFR-TKI Treatment | Male or Female | The Age of 18 Years Old or... and other conditions
-
AstraZenecaNo longer available